Boothbay Fund Management’s Rein Therapeutics RNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding RNTX
Boothbay Fund Management's RNTX Position: Q3 2026 in Review
Boothbay Fund Management held its Rein Therapeutics (RNTX) position steady in Q3 2026 at 889,450 shares worth $715K. The position accounts for 0.01% of the portfolio, ranked #1162.
Boothbay Fund Management first reported a position in RNTX in Q1 2021 and has held it in 8 quarters since. The position peaked at $925K in Q2 2026. 64 funds tracked by Wall St. Rank hold RNTX as of Q3 2026.
- Boothbay Fund Management held 889,450 shares of Rein Therapeutics worth $715K as of Q3 2026.
- Boothbay Fund Management left its Rein Therapeutics share count unchanged in Q3 2026.
- Rein Therapeutics made up 0.01% of Boothbay Fund Management's portfolio in Q3 2026, its #1162 holding.
- Boothbay Fund Management first reported a position in Rein Therapeutics in Q1 2021 and has held it in 8 quarters since.
- Boothbay Fund Management's Rein Therapeutics position peaked at $925K in Q2 2026.
- 64 funds tracked by Wall St. Rank held Rein Therapeutics as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.